FOXO4-DRI

Description

FOXO4-DRI is a synthetic retro-inverso peptide research material composed primarily of D-amino-acid residues arranged to preserve selected spatial characteristics of a corresponding peptide interaction sequence while providing a structurally distinct backbone orientation. It is produced through controlled peptide synthesis and used in laboratory settings for analytical, biochemical, peptide-protein interaction, and molecular research under defined experimental conditions. The material is commonly supplied in lyophilized form to support stability and integrity during appropriate laboratory storage and handling.

Research Applications:

FOXO4-DRI may be utilized in controlled laboratory research settings for applications such as:

• Analytical characterization of retro-inverso peptide structure, identity, and physicochemical properties
• Investigation of FOXO4-associated peptide-protein interactions in controlled biochemical assay systems
• Evaluation of peptide stability and degradation behavior involving D-amino-acid-containing sequences
• Examination of molecular interaction and structure-activity relationships in controlled biochemical and cell-based research models

Storage and Handling:

• Store lyophilized material at -20°C or according to batch-specific supplier documentation.
• Protect the material from excessive moisture, heat, and prolonged light exposure.
• Once prepared in solution, storage conditions should follow validated stability data and the requirements of the specific laboratory protocol.
• Avoid unnecessary repeated freeze-thaw cycles and use appropriate laboratory handling procedures to minimize contamination and degradation.

Product Specifications:

• Purity: Refer to batch-specific HPLC and mass-spectrometry results or Certificate of Analysis
• Appearance: Typically supplied as a white to off-white lyophilized powder; verify against batch-specific documentation
• Solubility: Dependent on concentration, pH, counterions, formulation, and solvent system; refer to supplier-specific technical documentation

Compliance Notice:

FOXO4-DRI is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product is supplied exclusively for controlled laboratory, analytical, and in vitro research purposes and is not intended for diagnostic, therapeutic, or clinical applications. Misuse of this product is strictly prohibited and may violate applicable federal, state, or local laws. By purchasing this product, the buyer represents and warrants that it will be used solely for legitimate laboratory research purposes.

Technical Note: The designation FOXO4-DRI refers to a D-retro-inverso peptide, and commercial research preparations may differ in exact sequence notation, terminal configuration, salt form, counterions, or purification format. The molecular formula C₁₆₃H₂₆₇N₅₃O₅₁ and calculated molecular weight of approximately 3785.3 g/mol shown above correspond to the specified 34-residue free-peptide sequence without additional counterions or terminal modifications. Final product-page specifications should therefore match the supplier documentation, mass-spectrometry data, and batch-specific Certificate of Analysis (COA).